AtaiBeckley (ATAI) Long-Term Debt Issuances (2020 - 2023)
AtaiBeckley's (ATAI) quarterly Long-Term Debt Issuances came in at $20000.0 in Q4 2023, down 99.86% quarter-over-quarter from $13.9 million in Q3 2022.
AtaiBeckley (ATAI) Long-Term Debt Issuances (2020 - 2023) Analysis & Trends
AtaiBeckley has disclosed Long-Term Debt Issuances across 4 years of filings, most recently posting $20000.0 for Q4 2023.
- Long-Term Debt Issuances for Q4 2023 came in at $20000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $20000.0 (down 99.86% YoY), and the FY2023 annual result was $20000.0, down 99.87% from the prior year.
- Long-Term Debt Issuances came in at $20000.0 for Q4 2023 at AtaiBeckley, down from $13.9 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $18.1 million in Q3 2020 to a low of -$6.1 million in Q4 2021.
- The 4-year median for Long-Term Debt Issuances is $2.8 million (2021), against an average of $5.3 million.
- Across the five-year window, Long-Term Debt Issuances sank 186.67% in 2021 and surged 210.85% in 2022, its largest moves.
- AtaiBeckley's Long-Term Debt Issuances stood at $7.0 million in 2020, then tumbled by 186.67% to -$6.1 million in 2021, then surged by 329.49% to $13.9 million in 2022, then slumped by 99.86% to $20000.0 in 2023.
- The last three Long-Term Debt Issuances figures came in at $20000.0 (Q4 2023), $13.9 million (Q3 2022), and $1.1 million (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.73 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2022 | 13.92 Mn |
| Sep 30, 2022 | 13.92 Mn |
| Jun 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1.08 Mn |
| Dec 31, 2021 | -6.07 Mn |
| Dec 31, 2021 | -6.07 Mn |
| Sep 30, 2021 | 4.48 Mn |
| Sep 30, 2021 | 4.48 Mn |
| Jun 30, 2021 | 832,000.00 |
| Jun 30, 2021 | 832,000.00 |
| Mar 31, 2021 | 756,000.00 |
| Mar 31, 2021 | 756,000.00 |
| Dec 31, 2020 | 7.00 Mn |
| Dec 31, 2020 | 7.00 Mn |
| Sep 30, 2020 | 18.06 Mn |
| Sep 30, 2020 | 18.06 Mn |
| Jun 30, 2020 | 12.71 Mn |
| Jun 30, 2020 | 12.71 Mn |